Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALB Albemarle	$81.30 +3.0%	$71.27	$49.43 ▼ $113.91	$9.57B	1.63	5.16 million shs	2.88 million shs
MRNA Moderna	$27.12 +3.4%	$29.18	$23.15 ▼ $84.28	$10.55B	1.83	8.20 million shs	9.16 million shs
NOW ServiceNow	$885.79 +1.0%	$955.00	$678.66 ▼ $1,198.09	$184.44B	0.93	1.87 million shs	1.08 million shs

10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALB Albemarle	+3.04%	-1.07%	+3.12%	+41.04%	-8.24%
MRNA Moderna	+3.43%	-3.21%	-21.78%	+3.27%	-68.70%
NOW ServiceNow	+0.92%	+2.18%	-7.50%	-11.91%	+5.61%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALB Albemarle	3.1577 of 5 stars	1.9	2.0	2.5	0.6	3.5	1.7	0.6
MRNA Moderna	4.5167 of 5 stars	4.0	2.0	0.0	4.6	2.6	2.5	0.6
NOW ServiceNow	4.9206 of 5 stars	4.4	5.0	0.0	2.5	3.4	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALB Albemarle	1.88	Reduce	$89.17	9.68% Upside
MRNA Moderna	2.04	Hold	$42.88	58.12% Upside
NOW ServiceNow	2.88	Moderate Buy	$1,115.20	25.90% Upside

Current Analyst Ratings Breakdown

Latest NOW, ALB, and MRNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/22/2025	MRNA Moderna	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underperform ➝ Underperform	$18.00 ➝ $15.00
8/18/2025	ALB Albemarle	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$60.00 ➝ $80.00
8/4/2025	ALB Albemarle	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Hold ➝ Hold	$74.00
8/4/2025	MRNA Moderna	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$40.00 ➝ $31.00
8/4/2025	NOW ServiceNow	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$1,300.00
8/1/2025	MRNA Moderna	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$32.00
8/1/2025	MRNA Moderna	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$26.00
8/1/2025	MRNA Moderna	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$40.00
8/1/2025	MRNA Moderna	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$32.00
8/1/2025	ALB Albemarle	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$65.00 ➝ $70.00
8/1/2025	ALB Albemarle	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$75.00 ➝ $70.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALB Albemarle	$5.38B	1.78	$3.83 per share	21.25	$70.22 per share	1.16
MRNA Moderna	$3.24B	3.26	N/A	N/A	$24.16 per share	1.12
NOW ServiceNow	$10.98B	16.77	$12.70 per share	69.74	$52.56 per share	16.85

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALB Albemarle	-$1.18B	-$9.32	N/A	42.56	N/A	-18.61%	-1.87%	-0.89%	11/5/2025 (Estimated)
MRNA Moderna	-$3.56B	-$7.53	N/A	N/A	N/A	-94.31%	-25.96%	-20.09%	11/6/2025 (Estimated)
NOW ServiceNow	$1.43B	$7.94	111.56	77.09	4.00	13.78%	18.04%	8.81%	10/22/2025 (Estimated)

Latest NOW, ALB, and MRNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/1/2025	Q2 2025	MRNA Moderna	-$2.99	-$2.13	+$0.86	-$2.13	$116.26 million	$142.00 million
7/30/2025	Q2 2025	ALB Albemarle	-$0.83	$0.11	+$0.94	-$0.16	$1.23 billion	$1.33 billion
7/23/2025	Q2 2025	NOW ServiceNow	$3.57	$4.09	+$0.52	$1.84	$3.12 billion	$3.22 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALB Albemarle	$1.62	1.99%	N/A	N/A	30 Years
MRNA Moderna	N/A	N/A	N/A	N/A	N/A
NOW ServiceNow	N/A	N/A	N/A	N/A	N/A

Latest NOW, ALB, and MRNA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/22/2025	ALB Albemarle	quarterly	$0.4050	1.94%	9/12/2025	9/12/2025	10/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALB Albemarle	0.38	2.31	1.47
MRNA Moderna	N/A	3.93	3.77
NOW ServiceNow	0.14	1.09	1.09

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALB Albemarle	92.87%
MRNA Moderna	75.33%
NOW ServiceNow	87.18%

Insider Ownership

Company	Insider Ownership
ALB Albemarle	0.33%
MRNA Moderna	11.00%
NOW ServiceNow	0.38%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALB Albemarle	8,300	117.68 million	117.30 million	Optionable
MRNA Moderna	5,800	389.08 million	346.28 million	Optionable
NOW ServiceNow	26,293	208.00 million	207.21 million	Optionable

NOW, ALB, and MRNA Headlines

Recent News About These Companies

ServiceNow (NYSE:NOW) Shares Up 1.7% - Still a Buy?

August 23 at 5:16 PM | marketbeat.com

Titan Global Capital Management USA LLC Sells 5,815 Shares of ServiceNow, Inc. $NOW

August 23 at 9:00 AM | marketbeat.com

Laffer Tengler Investments Inc. Purchases 452 Shares of ServiceNow, Inc. $NOW

August 23 at 8:43 AM | marketbeat.com

RPG Investment Advisory LLC Raises Position in ServiceNow, Inc. $NOW

August 23 at 8:32 AM | marketbeat.com

Circle Wealth Management LLC Boosts Holdings in ServiceNow, Inc. $NOW

August 23 at 8:14 AM | marketbeat.com

3 No-Brainer Growth Stocks to Buy Right Now

August 23 at 7:46 AM | fool.com

Bragg Financial Advisors Inc Acquires Shares of 1,532 ServiceNow, Inc. $NOW

August 23 at 7:26 AM | marketbeat.com

EntryPoint Capital LLC Invests $370,000 in ServiceNow, Inc. $NOW

August 23 at 5:36 AM | marketbeat.com

ServiceNow (NOW) Expands AI Reach With DFL Partnership in German Football

August 23 at 4:35 AM | msn.com

ServiceNow, Inc. (NOW) Partners with DFL Deutsche Fußball Liga

August 23 at 4:35 AM | msn.com

ServiceNow (NYSE:NOW) Insider Sells $1,299,612.60 in Stock

August 22 at 5:26 PM | marketbeat.com

ServiceNow (NYSE:NOW) CEO Sells $1,426,500.00 in Stock

August 22 at 5:26 PM | marketbeat.com

Insider Selling: ServiceNow (NYSE:NOW) General Counsel Sells 1,698 Shares of Stock

August 22 at 5:26 PM | marketbeat.com

Rep. Lisa C. McClain Sells Off Shares of ServiceNow, Inc. (NYSE:NOW)

August 22 at 5:06 PM | marketbeat.com

ServiceNow (NYSE:NOW) Trading Down 1.1% - Should You Sell?

August 22 at 1:46 PM | marketbeat.com

Why Is ServiceNow (NOW) Down 12% Since Last Earnings Report?

August 22 at 12:36 PM | zacks.com

ServiceNow, Inc. $NOW Stock Holdings Lessened by Ameriprise Financial Inc.

August 22 at 9:01 AM | marketbeat.com

Norinchukin Bank The Increases Holdings in ServiceNow, Inc. $NOW

August 22 at 8:50 AM | marketbeat.com

How ServiceNow Is Turning AI Strategy Into Real Revenue

...

August 22 at 8:17 AM | marketbeat.com

CW Advisors LLC Has $22.30 Million Stake in ServiceNow, Inc. $NOW

August 22 at 8:12 AM | marketbeat.com

ServiceNow (NYSE:NOW) Stock Acquired Rep. Lisa C. McClain

August 22 at 8:06 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NOW, ALB, and MRNA Company Descriptions

Albemarle NYSE:ALB

$81.30 +2.36 (+2.99%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$81.90 +0.60 (+0.74%)

As of 08/22/2025 07:59 PM Eastern

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Moderna NASDAQ:MRNA

$27.12 +0.90 (+3.43%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$27.13 +0.01 (+0.04%)

As of 08/22/2025 07:59 PM Eastern

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

ServiceNow NYSE:NOW

$885.79 +8.82 (+1.01%)

Closing price 08/22/2025 03:59 PM Eastern

Extended Trading

$887.93 +2.14 (+0.24%)

As of 08/22/2025 07:59 PM Eastern

ServiceNow, Inc. provides end to-end intelligent workflow automation platform solutions for digital businesses in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally. The company operates the Now platform for end-to-end digital transformation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, and collaboration and development tools. It also provides asset management, cloud observability, integrated risk management; information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; strategic portfolio management product suite; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT asset management; and security operations that connects with internal and third party. In addition, the company offers integrated risk management product to manage risk and resilience; environmental, social and governance management product; human resources, legal, and workplace service delivery products; customer service management product; and field service management applications. Further, the company provides app engine product; automation engine; platform privacy and security product; and source-to-pay operations. It serves to government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products through service providers and resale partners. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. ServiceNow, Inc. was founded in 2004 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time